The European Union Drugs Agency (EUDA) is the leading authority on illicit drugs in Europe. Based in Lisbon, Portugal, the EUDA provides independent scientific evidence and analysis on all aspects of this constantly changing threat to individual lives and wider society. The EUDA contributes to EU and national policies to protect Europe's citizens from drug-related harms. It is an agency of the European Union.
Our new mission focuses on contributing to European Union (EU) preparedness on drugs through four main actions: anticipate, alert, respond, and learn.
Drug Consumption Rooms, a Pillar of Harm Reduction and Human Rights : Sharing Experiences and Challenges of Drug Public Policy
For almost 40 years, the Drug Consumption Rooms (DCRs) have been providing effective solutions in terms of harm reduction, human rights and public health.
Our two week in-person Summer School (23rd of June to 04th of July 2025) prepares professionals and students to meet the complex policy challenges that face Europe and the World in the field of drugs. Teaching staff include scientific experts from the EUDA, researchers, practitioners and policymakers.
Our two week online Winter School (10th of March to 21th March 2025) prepares professionals and students to meet the complex policy challenges that face Europe and the World in the field of drugs. Teaching staff include scientific experts from the EUDA, researchers, practitioners and policymakers.
It is our pleasure to invite you to participate in The 5th International Annual Congress on Controversies on Cannabis-Based Medicines (Med-Cannabis2024) which will take place 31 October – 1 November 2024 in Vienna, Austria.
Brussels, 26 - 27 November 2024
The European Union (EU) is at a critical point in addressing drug-related violence. This violence comes in many forms and is growing in complexity. It feeds on the organised crime occurring in fragile social environments, affecting communities and perpetuating a range of problems.
How is Europe's opioid market evolving? What substances are causing the most concern today? How are countries responding to cannabis use? Find out more when the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) launches its European Drug Report 2024: Trends and Developments in a live online press conference on 11 June.
In view of the fast-moving developments in the field of Artificial Intelligence (AI), this webinar seeks to discuss opportunities and challenges of using AI for evidence-based research.
